Andrea Angioi, MD, FASN
@andreaangioi
Followers
268
Following
315
Statuses
276
🌿 Sardinian Heart, Father of two gems, Kidney Specialist | Nature's student, health's guardian | Mayo Clinic Research Fellow 4 Life
Cagliari, Sardinia
Joined August 2011
@rc_oncneph @ShrutiGkidney @MayoClinicNeph @pittkidneyctr @DanaFarber @harvardmed Congrats man! Big score!
0
0
1
RT @PRomagnani: Anti-slit diaphragm antibodies in autoimmune podocytopathy: •Anti-nephrin → frequent in kids •Anti-podocin → in kids & adul…
0
73
0
Mauro Morandi, Italy’s Robinson Crusoe, Dies at 85
0
0
0
RT @SethiRenalPath: Simple concept of GN. It’s all about location! 1. Subendothelial deposits/injury by Ig, immune-complexes, complement,…
0
205
0
RT @NDTsocial: The plethora of immunomodulatory drugs: opportunities for immune-mediated kidney diseases ➡️ This review highlights promisi…
0
18
0
RT @Kidney_Int: Insights from the BKEVER Trial comparing everolimus versus mycophenolate mofetil for BK Polyomavirus infection in kidney tr…
0
21
0
RT @KIReports: Patients with #IgA Nephropathy Show Abnormal Frequencies of #Bcell Subsets and Unconventional #TCells and High Levels of #Gd…
0
13
0
RT @MiskovicRada: 📍Should we consider early use of MMF in new-onset SLE with high dsDNA titer, without major organ involvement? 👉Study sho…
0
17
0
RT @edgarvlermamd: The 2025 Clinical Practice Guideline for the Anemia in CKD from @goKDIGO is out for public review ‼️ #KDIGOAnemiainCKD…
0
66
0
RT @JZRenalPath: HydrANCAzine strikes again. Pt on hydralazine developed a Necrotizing/crescentic GN with increased immune complex depositi…
0
32
0
RT @SethiRenalPath: A paradigm change in management of Lupus Nephritis (LN) In pts with proliferative LN & + anti-ds DNA, treatment should…
0
86
0
@FrontImmunol Over 90% ABMR incidence observed in patients with both 2 MICA mismatches and rs1049174[GG]. 🔍 This genetic combo signifies a “high-risk” group that may benefit from adjusted post-transplant protocols.
0
0
2
@FrontImmunol Patients on mTOR inhibitors with rs1049174[GG] or rs2255336[AA] SNPs had higher ABMR rates vs. those on CNIs. 🌟 Selecting the right immunosuppressant based on genetic profiles could transform patient outcomes!
0
0
1
@FrontImmunol Two MICA allele mismatches in donor-recipient pairs are linked to higher ABMR risk (52.7% at 10 years). MICA typing might be vital in kidney transplant compatibility assessments.
0
0
1
@FrontImmunol Patients with rs1049174[GG] in NKG2D show a 61.8% ABMR incidence at 10 years post-transplantation vs. 40.0% for [CC]. This SNP could guide personalized immunosuppression strategies to improve graft survival!
0
0
1
RT @SethiRenalPath: Immunotactoid glomerulopathy (ITG): 45-yr old with hematuria, proteinuria, Non-Hodgkin lymphoma LM: MPGN pattern IF:…
0
32
0